What is Chest Drainage Catheters Market?
Chest drainage is the process of draining out the air or fluid which is caused by infections or injury. To carry out this process, the chest drainage catheter is used to take out the fluid that is present between the lungs and the chest wall. The tube is a soft silicone pipe and prevents scarring of tissue and debris adhesion. This process is performed by radiologists and surgeons, and the size of catheters is used according to the requirement. The chest drainage catheter is having high demand due to the rising chronic diseases. Hence the market is growing.
Highlights from Chest Drainage Catheters Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Medtronic plc (Ireland), Maquet Holding B.V. & Co. KG (Germany), Terumo Corporation (Japan), Teleflex Incorporated (United States), Cook Medical Incorporated (United States), Rocket Medical Plc (United Kingdom), Smith’s Medical (United States), Medline (United States), Mediplus (India) and Medela (Switzerland) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players explore new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Chest Drainage Catheters market throughout the forecasted period.
Medtronic plc (Ireland), Maquet Holding B.V. & Co. KG (Germany), Terumo Corporation (Japan), Teleflex Incorporated (United States), Cook Medical Incorporated (United States), Rocket Medical Plc (United Kingdom), Smith’s Medical (United States), Medline (United States), Mediplus (India) and Medela (Switzerland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Redax (Italy), Argon (United States), PAHSCO (United States) and Diversatek (United States). Chest Drainage Catheters Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Clinics, Hospitals and Others |
Type | Regular Chest Drainage Catheters and Thoracentesis Catheters |
Chest drainage system | Two component,Three component |
On the basis of geography, the market of Chest Drainage Catheters has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Growing Expenditure on Health Care
Market Growth Drivers:
Rising Prevalence of Cardio Vascular Diseases and Increasing Demand for Minimal Invasive Surgical Process
Challenges:
Lesser Adoption of Technologies in Under Developed and Developing Countries
Restraints:
High Costs Associated with the Treatment can hamper the Market and Lack of Skilled Professionals Required to Operate
Opportunities:
Technological Innovations in Health Care Devices are Affecting the Market Positively and Government Initiatives Towards the Health Care Facilities
Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organizations
Market Leaders & Development Strategies
In 2019, Medtronic plc. acquired Titan Spine which is a titanium spine interbody implant and surface technology company. This acquisition will help the company to provide best-in-class solutions for spine surgeons.
Manufacturers are developing chest drainage catheters that prioritize patient comfort and mobility. This includes using softer and more flexible materials, designing catheters with ergonomic considerations, and developing systems that allow patients to move and ambulate more easily.
In the United States, the Food and Drug Administration (FDA) is the regulatory body responsible for the oversight of medical devices, including chest drainage catheters. The FDA ensures that medical devices meet safety and efficacy standards through pre-market clearance or approval processes.